Literature DB >> 8748546

Molecular epidemiology of Mycoplasma mycoides subsp. mycoides biotype Small Colony, the agent of contagious bovine pleuropneumonia.

F Poumarat1, M Solsona.   

Abstract

Restriction endonuclease analysis (REA) and immunoblotting were used to compare field strains of Mycoplasma mycoides subsp. mycoides biotype Small Colony from different parts of Europe and Africa. Of the 27 strains tested by REA, the European ones (n = 15), except 3 from the Iberian peninsula, differed strikingly from the African ones (n = 10). Vaccinal strains T1-SR and KH3J had a unique REA pattern. Polyclonal immunoblot profiles of 46 strains appeared fairly similar. However most of the Italian strains (22 out of 24) shared a characteristic, in the 100 kDa area, unlike that of the other European strains. Immunoprofiles of the reference strain PG1 and vaccinal strain T1-SR were different from the others. These results allowed the determination of possible links between different geographic region of enzootic contagious bovine pleuropneumonia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8748546     DOI: 10.1016/0378-1135(95)00115-8

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  3 in total

1.  Characterization of strains of Mycoplasma mycoides subsp. mycoides small colony type isolated from recent outbreaks of contagious bovine pleuropneumonia in Botswana and Tanzania: evidence for a new biotype.

Authors:  J B March; J Clark; M Brodlie
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

2.  Amplified-fragment length polymorphism fingerprinting of Mycoplasma species.

Authors:  B Kokotovic; N F Friis; J S Jensen; P Ahrens
Journal:  J Clin Microbiol       Date:  1999-10       Impact factor: 5.948

3.  Genomic differences between type strain PG1 and field strains of Mycoplasma mycoides subsp. mycoides small-colony type.

Authors:  Daniela F Bischof; Edy M Vilei; Joachim Frey
Journal:  Genomics       Date:  2006-08-17       Impact factor: 5.736

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.